Redcliffe Labs Competitors and Similar CompaniesClear all
Redcliffe Labs's competitors and similar companies include PathoFinder, Sirigen, Enable Biosciences and Hummingbird Diagnostics.
 Redcliffe Labs Redcliffe Labs (also known as Redcliffe Lifetech, Redcliffe Lifescience) is a provider of health packages and diagnostic services. |  Enable Biosciences Enable Biosciences is a biotech company that develops ultrasensitive immunoassays permitting early detection and treatment of autoimmune and infectious diseases. |  Hummingbird Diagnostics Hummingbird Diagnostics is a company focused on disease screening, symptom-based diagnostics, disease-specific prognostics, as well as monitoring of patient-centric therapies. | |||
Founding Date | Founding Date 2018 | Founding Date 2004 | Founding Date 2003 | Founding Date 2015 | Founding Date 2006 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Noida, IN HQ | Locations Maastricht, NL HQ | Locations San Diego, US HQ | Locations San Francisco, US HQ | Locations Heidelberg, DE HQ |
Employees | Employees 1,7481% increase | Employees 343% decrease | Employees 9 | Employees 14 | Employees 303% increase |
Funding | |||||
Latest funding round | Latest funding round $ 61m (about 4 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.5m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 61m | Total funding raised N/A | Total funding raised $ 19.1m | Total funding raised $ 3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Enable Biosciences
HQ
San Francisco, US
Employees
14
Enable Biosciences is a biotech company that develops ultrasensitive immunoassays permitting early detection and treatment of autoimmune and infectious diseases.
View companyHummingbird Diagnostics
HQ
Heidelberg, DE
Employees
30↑ 3% increase
Hummingbird Diagnostics is a company focused on disease screening, symptom-based diagnostics, disease-specific prognostics, as well as monitoring of patient-centric therapies.
View company